Updated Jul 16, 2026
Pande Atul has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $521K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-26 | IMVT | Immunovant, Inc. | S — Open-market sale | 1.5K | $38.01 | $57K |
| 2026-06-26 | IMVT | Immunovant, Inc. | M — Option exercise | 1.5K | $8.43 | $13K |
| 2026-06-16 | IMVT | Immunovant, Inc. | S — Open-market sale | 1.5K | $34.02 | $51K |
| 2026-06-16 | IMVT | Immunovant, Inc. | M — Option exercise | 1.5K | $8.43 | $13K |
| 2026-05-21 | IMVT | Immunovant, Inc. | S — Open-market sale | 6.0K | $32.00 | $192K |
| 2026-05-21 | IMVT | Immunovant, Inc. | M — Option exercise | 6.0K | $8.43 | $51K |
| 2026-04-09 | IMVT | Immunovant, Inc. | A — Grant or award | 13.9K | $0.00 | |
| 2024-12-04 | IMVT | Immunovant, Inc. | S — Open-market sale [10b5-1] | 7.8K | $28.54 | $221K |
Pande Atul is a corporate insider — currently tracked as Director of Immunovant, Inc. (IMVT). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($521K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Pande Atul profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.